Additional file 4 of Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial
posted on 2021-05-05, 03:40authored byDeonna M. Ackermann, Amelia K. Smit, Monika Janda, Cathelijne H. van Kemenade, Mbathio Dieng, Rachael L. Morton, Robin M. Turner, Anne E. Cust, Les Irwig, Jolyn K. Hersch, Pascale Guitera, H. Peter Soyer, Victoria Mar, Robyn P. M. Saw, Donald Low, Cynthia Low, Dorothy Drabarek, David Espinoza, Jon Emery, Peter Murchie, John F. Thompson, Richard A. Scolyer, Anthony Azzi, Alister Lilleyman, Katy J. L. Bell